Northern New Jersey-area residents now have access to advanced head and neck cancer care with the establishment of the Valley-Mount Sinai Head and Neck Institute at Valley-Mount Sinai Comprehensive Cancer Care in Paramus. The Institute’s multispecialty team excels in providing outstanding, personalized clinical care for the treatment of patients with cancers of the mouth, throat, head and neck.
The Valley-Mount Sinai Head and Neck Institute was established as part of Valley – Mount Sinai Comprehensive Cancer Care, Valley’s partnership with The Mount Sinai Health System, which offers the residents of northern New Jersey state-of-the-art, comprehensive cancer care.
“Our growing partnership has enabled us to build upon our strong oncology program to offer the skill and expertise of physicians from Mount Sinai to our patients”, said Ephraim Casper, M.D., Chief Medical Officer, Valley-Mount Sinai Comprehensive Cancer Care. “Now patients can see Mount Sinai specialists who are offering breakthrough treatments for head and neck cancers, as well as the expert team of Valley medical and radiation oncologists, right here in Paramus.”
“The establishment of the Valley-Mount Sinai Head and Neck Institute addresses an unmet need in this area,” said Eric M. Genden, M.D., Isidore Friesner Chair of the Department of Otolaryngology-Head and Neck Surgery at the Mount Sinai Health System. “We are proud to partner with Valley Health System to help further advance the care of patients with head and neck cancer in this region.”
The Valley-Mount Sinai Head and Neck Institute is backed by Mount Sinai’s Head and Neck Cancer team, which features 35 specialists from 12 different disciplines who come together to provide every patient with the benefit of a multidisciplinary approach. Valley patients will also have access to the latest clinical trials through Mount Sinai’s Head and Neck Research Program.
Specialists at Mount Sinai have accomplished what was once unthinkable in treating head and neck cancer — achieving an optimal outlook while preserving function. This includes using minimally invasive robotic surgery and organ-preserving therapeutics to not only treat the disease, but also to allow patients to continue their normal lives.
The Institute also offers a unique Patients First Program, which provides unparalleled service to meet each patient’s unique needs to help that patient access a provider as quickly as possible.
To access more business news, visit NJB News Now.Related Articles: